Lixisenatide attenuates advanced glycation end products (AGEs)-induced degradation of extracellular matrix in human primary chondrocytes
Osteoarthritis (OA) poses a growing threat to the health of the global population. Accumulation of advanced glycation end-products (AGEs) has been shown to upregulate expression of degradative enzymes such as matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinase with thrombospondi...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artikel |
| Taal: | Engels |
| Gepubliceerd in: |
Taylor & Francis Group
2019-12-01
|
| Reeks: | Artificial Cells, Nanomedicine, and Biotechnology |
| Onderwerpen: | |
| Online toegang: | https://www.tandfonline.com/doi/10.1080/21691401.2019.1593996 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|